AzTrials
AzTrials

DepressionBRIDGENCT04347707

Building Regulation in Dual Generations

A study testing BRIDGE Therapy Program in people with Depression and Self-regulation, run by University of Manitoba at 1 site in Canada.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Families who experience maternal mental illness and a variety of chronic stressors are currently underserved by the parenting programs. The investigators propose that impairments in maternal self-regulation, which result in unsupportive parenting, directly impact children's own self-regulation and neurobiology… Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Depression, Self-regulation, Child Development
What is being tested?
BRIDGE Therapy Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
1 siteCanada
Study dates
15 Sep 2019to 1 Jun 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Must have a 3-5 year old child
  • The child must not have a diagnosed developmental delay
  • Must have full or joint custody of the child
  • Must meet current criteria for a Major Depressive Episode
  • Must be 18 years of age

Who cannot join

  • Child is outside of the 3-5 year old age range
  • The child has a diagnosed developmental delay
  • Mother does not have full or joint custody of the child
  • Mother did not meet current criteria for a Major Depressive Episode (control group)

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • University of Manitoba

    Winnipeg, Manitoba, R3T 2N2

Other trials in Canada

About this study

Official title: Building Regulation in Dual Generations: Pilot Study

Families who experience maternal mental illness and a variety of chronic stressors are currently underserved by the parenting programs. The investigators propose that impairments in maternal self-regulation, which result in unsupportive parenting, directly impact children's own self-regulation and neurobiology, leading to risk for intergenerational transmission of mental illness. The objective of this study is to develop and evaluate a program that is targeted at improving underlying self-regulatory mechanisms in both mothers with depression and their 3 to 5-year-old children. It is hypothesized that children exposed to maternal mental illness will have greater self-regulatory deficits across emotional and behavioural domains, compared to children not exposed to mental illness. The effects of maternal mental illness are expected to be compounded for children of mothers reporting a higher degree of chronic stressors, including poverty, housing instability, violence, and low social support. Further, it is hypothesized that taking a dual-generation intervention approach to addressing self-regulatory mechanisms underlying psychopathology at the level of the mother, child, and dyad (i.e. parenting interactions) will improve both maternal capacities and child outcomes. The objectives for this study are to 1) establish a better understanding of the self-regulatory processes that are altered in preschool-aged children exposed to maternal mental illness, and determine the mediating role of parenting behaviours, as well as the moderating impact of chronic stress exposure; and 2) develop and evaluate a novel dual-generation intervention for mothers with mental illness and their 3 to 5-year-old children based on existing gold-standard evidence-based approaches.

Read the detailed description

Exposure to maternal mental illness early in life can have a negative effect on children's own mental health and behavior problems putting them at risk for intergenerational transmission of mental illness (Comaskey et al., 2017; Reupert, Maybery, Nicholson, Gopfert, \& Seeman, 2015; Goodman et al., 2011; O'Connor, Monk, \& Burke, 2016; Dean et al., 2018; Roos et al., 2016). In order to address this concern, there have been recent calls for action for the development of early intervention programs (Shonkoff, 2016; Chartier, 2016; Patel et al., 2016; Waddell et al., 2007) that support both mother and child in a dual generation capacity (Luthar \& Eisenberg, 2017; Shonkoff \& Fisher, 2013). In this study, the investigators are particularly interested in the mechanisms involved in maternal self-regulation, defined as the effortful regulation of one's emotions and behaviors and what effect it has on children's self-regulation. The investigators propose that dysfunction in maternal self-regulation serves as a risk factor for the intergenerational transmission of mental illness. Partially due to the fact that dysregulation in mother's own emotions puts them at risk for mental illness and can also lead to challenges in developmentally supportive parenting (Aldao, Gee, De Los Reyes, \& Seager, 2016; Kochanska, Philibert, \& Barry, 2009; Strauman, 2017; Zeytinoglu, Calkins, Swingler, \& Leerkes, 2017) such as scaffolding emotional socialization, stress management, impulse control (Zeytinoglu et al., 2017, Crandall, Deater-Deckard, \& Riley, 2015) and often at times leads to implementation of poor parenting practices (Choi et al., 2018; Dittrich et al., 2018). Children ages 3-5 are of particular interest as they are in a developmentally sensitive period of self-regulation skills (Blair \& Diamond, 2008; Gilliom, Shaw, Beck, Schonberg, \& Lukon, 2002; Woodward, Lu, Morris, \& Healey, 2017). The aim of this study is to gain further insight into what factors of maternal mental illness are most relevant to the development of children's self-regulatory impairments and negative outcomes. The study will also investigate how exposure to chronic stress interacts with maternal mental illness to affect development. The investigators are especially interested in studying the effects of chronic stress exposure on biological stress-related systems such as the hypothalamic-pituitary-adrenal axis (HPA) and the autonomic nervous system (ANS) to see how intervention can target these systems.

The study has two primary objectives:

  1. Establish a better understanding of the self-regulatory processes that are altered in preschool-aged children exposed to maternal mental illness, and determine the mediating role of parenting behaviours, as well as the moderating impact of chronic stress exposure The investigators predict that children with mothers who have a mental illness will have more self-regulatory deficits and that this relationship will be partially mediated by parenting skills. Whereas the effects of maternal mental illness will be exacerbated by exposure to chronic stress.
  2. Develop and evaluate a novel dual-generation intervention for mothers with mental illness and their 3 to 5-year-old children based on existing gold-standard evidence-based approaches. The investigators predict that our dual generation approach to intervention will improve self-regulatory outcomes in both mother and child.

Methodology

Intervention Group:

Mothers experiencing symptoms of mental illness will be recruited from the local agencies serving this population and the general community. All interested participants will be phone screened to determine eligibility. If a participant passes the phone screener questionnaire, they will be scheduled for the intake interview in which a PhD level clinical psychology graduate student will complete the MINI Neuropsychiatric Interview (Sheehan et al., 1997) to determine if the participant has experienced a recent major depressive episode. If this is found to be the case, the participant is scheduled for a 2.5 hour laboratory assessment (T1) in which mother and child will participate a variety of self-report, behavioral, and biological assessments (see primary outcome measures for more details).

After the T1 assessment, mothers will participate in the novel BRIDGE Therapy Program, which occurs once a week for 2 hours for 20 weeks. The BRIDGE Therapy Program is a mix of Dialectical Behaviour Therapy (DBT) and parent skills training. DBT aims to support clients in achieving "a life worth living" by reducing self-destructive behaviours and scaffolding self-regulatory skills while acknowledging the inherently difficult experiences individuals have endured (Valentine, Bankoff, Poulin, Reidler, \& Pantalone, 2015). DBT has proven to be effective in treating a wide range of mental illnesses characterized by self-regulatory deficits (Valentine et al., 2015; Tomlinson \& Hoaken, 2017; Behavioral Research \& Therapy Clinics, 2018). DBT content also shares many characteristics with evidence-based interventions aimed at promoting childhood self-regulation (Maag, 2016; Bierman \& Motamedi, 2015), and because of this, the parenting component of the BRIDGE Therapy program is matched to the four DBT modules; mindfulness, interpersonal effectiveness, emotion regulation, and distress tolerance. Throughout the program, data will be collected weekly on attendance, DBT/parenting skill implementation through the use of diary cards, and at weeks 2, 9, 15 on child behavior and symptoms of depression (see secondary outcome measures).

After the completion of the 20-week BRIDGE Therapy Program participants will come in for a second laboratory assessment (T2) which will follow identical procedures to those outlined in T1.

Participants will be compensated for their time at each assessment on an ascending pay scale. They will be provided with $30.00 compensation for their intake interview, $60.00 for assessment 1, and $90.00 for assessment 2. The ascending pay scale is provided to encourage retention and has been used in previous projects by the primary researcher and collaborators. Furthermore, systematic efforts will be taken to reduce barriers to treatment and encourage retainment. Participants will be aided in transportation costs (i.e. bus tickets) and provided with meals and childcare services while in group therapy sessions and for lab visits.

Control Group:

A sample of household income and age-matched mother-child dyads not exposed to maternal mental illness will be recruited and participate in identical intake and assessment (T1) procedures to the ones described above. The primary goal of the income-matched control families is to provide comparison information about baseline differences in child characteristics associated with maternal mental illness that informs the directionality of expected intervention effects.

Planned Analyses:

The investigators will examine the extent to which our measures are related using correlational analyses. The investigators will use Mplus software to examine multivariate analyses. Mother age, child age, and child gender will be examined as covariates. Child gender will also be examined as a moderator in domains that have a theoretical and evidence base.

Objective 1. When group differences emerge, structural equation models will characterize the extent to which maternal self-regulation predicts child characteristics and parenting mediates effects. Chronic stress exposure will also be examined as a moderator of associations. Objective 2.To measure the effects of the intervention repeated measure analyses will be used to examine the changes in our primary measures for mothers and children in the BRIDGE Therapy program. Next, exploratory analyses will be used to determine the extent to which changes in maternal function predict changes in each child outcome. Structural equation models will be employed to identify the relative contributions of maternal characteristics to changes in child outcomes as well as moderating (i.e. chronic stress, child gender) and mediating (i.e. parenting) paths of interest.

Expected Outcomes:

The BRIDGE Therapy Program is a novel intervention that is designed to target self-regulatory deficits and prevent the inter-generational transmission of mental illness due to these deficits. The program addresses the gaps in the literature by targeting parenting skills and both mother and child mental health outcomes. Although this is just the pilot study of the program, data from this project will be used to influence further development of the program so that outcome measures can be further improved. By taking a rapid-cycle approach to the development of materials along with the precise evaluation of the mechanisms involved, the investigators are setting the stage for the program to be adapted to meet the needs of at-risk families and to be tested in a large-scale RCT. Furthermore, by evaluating the processes involved in self-regulation for children exposed to maternal mental illness and how they respond to the intervention will inform us of how maternal mental illness impacts development. The ultimate goal of the project is to develop a dual-generation program that can prevent the intergenerational transmission of mental illness and improve outcomes for at-risk families.

Being tested
BRIDGE Therapy Program
Keywords
maternal mental health, self-regulatory mechanisms
Medical subject headings
Depression, Self-Control

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BRIDGE Therapy ProgramBehavioural

    The BRIDGE Therapy Program is a novel structured form of therapy that incorporates key parenting concepts and related Dialectical Behavior Therapy (DBT) modules. The primary aim of the program is to promote self-regulation in the mother-child dyads. The program involves 20, once per week, scheduled group therapy sessions that last for 2 hours. There are two components of the program, the first is the DBT section, which will follow the DBT Skills Training Manual 2nd Edition and will target maternal mental health symptomology. The second section is the parent skill training materials, which have been designed to correspond to the 4 core DBT modules (Mindfulness, Emotion Regulation, Distress Tolerance, and Interpersonal Effectiveness) and to promote self-regulatory skill development and a positive parent-child relationship.

Study groups in NCT04347707
Study groupRoleWhat they receive
BRIDGE Clinical GroupExperimentalThis group of mother-child dyads will have mothers who have been screened for and met diagnostic criteria for depression. Mothers in this group will participate in the 20-week group therapy and parent skills training intervention.
Receives: Behavioral: BRIDGE Therapy Program
Baseline Comparison GroupNo interventionThis group of mother-child dyads will not meet diagnostic criteria for depression and will serve as a comparison group for baseline measures. Dyads will be matched to the BRIDGE clinical group based on household income and child age.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Maternal Depression from pre-intervention to post-intervention - Beck Depression Inventory

    21-item self-report inventory to measure symptoms and characteristics of depression. Participants respond to statements on a 0-3 likert scale. Higher scores indicate higher depression symptoms. The highest possible score is 60 and lowest possible score is 0.

    Measured: The Beck Depression Inventory will be completed by participants at Time 1 prior to the beginning of the BRIDGE Therapy Program and at Time once again after the program is complete (approx. 20 weeks after Time 1).

  2. Change in Maternal Emotion Regulation pre-intervention to post-intervention - Difficulties in Emotion Regulation Scale

    18-item self-report questionnaire with 6 sub-categories to measure emotion regulation. Participants respond to items on a 5-point likert scale. Higher scores suggest more severe problems with emotion regulation. The highest possible score is 90 and the lowest possible score is 18.

    Measured: The Difficulties in Emotion Regulation Scale will be completed by participants at Time 1 prior to the beginning of the BRIDGE Therapy Program and Time 2 once again after the program is complete (approx. 20 weeks after Time 1).

  3. Change in Parenting Stress from pre-intervention to post-intervention - Parenting Stress Index (Short form)

    36-item self-report measure filled out by parents to measure stress level within the context of parenting. Participants respond to items on a 5-point likert scale. There are 3 sub categories. Responses to each item in a sub-category are totalled and then the 3 subcategory scores are summed to represent a total stress score. Higher scores indicated higher levels of parenting stress. Normal scores fall within the 15th to 85th percentile, and scores above the 85th percentile represent clinically elevated levels of stress.

    Measured: The Parenting Stress Index (short form) will be completed by participants at Time 1 prior to the beginning of the BRIDGE Therapy Program and at Time 2 once again after the program is complete (approx. 20 weeks after Time 1).

Secondary outcomes (2)
  1. Change in the Child Behaviour Checklist from pre-intervention to post-intervention

    103-item questionnaire that asks parents to describe their child's behavioural and emotional problems within the past 2 months.

    Measured: The Child Behaviour Checklist will be completed by participants at Time 1 prior to the beginning of the BRIDGE Therapy Program and at Time 2 once again after the program is complete (approx. 20 weeks after Time 1).

  2. Change in Parental Sensitivity from pre-intervention to post-intervention

    Parent-child interactions will be video recorded after the child has participated in an acute stressor task. The interaction will be coded to measure levels of parental sensitivity using a novel coding scale.

    Measured: Parent-child interactions will be observed and video coded at Time 1 prior to the beginning of the BRIDGE Therapy Program and at Time 2 once again after the program is complete (approx. 20 weeks after Time 1).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2020
  2. Study start15 Sep 2019
  3. Primary completion1 Jun 2020
  4. Study completion1 Jun 2020

Why it stopped: The trial was ended after one year due to the suspension of in-person research as a result of the COVID-19 pandemic. We have returned to the program development stage as we explore telehealth alternative options.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
The study will recruit a group of mother-child dyads in which the mother meets the current criteria for depression. Those mothers will participate in a 20-week group therapy intervention that incorporates Dialectical Behavior Therapy (DBT) and parent skills training. A control group of mother-child dyads who will be income and child age-matched to the intervention sample will also be recruited. These mothers will not meet the criteria for depression and will not receive the group therapy intervention.
Masking
None (open label)
Enrolment
28 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04347707
Sponsor's protocol ID
P2019:063
Acronym
BRIDGE
Status last verified
Nov 2020
First submitted
8 Apr 2020
Last updated
18 Nov 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: It is not yet known if there will be a plan to make IPD available.

Publications

  • Comaskey B, Roos NP, Brownell M, Enns MW, Chateau D, Ruth CA, Ekuma O. Maternal depression and anxiety disorders (MDAD) and child development: A Manitoba population-based study. PLoS One. 2017 May 24;12(5):e0177065. doi: 10.1371/journal.pone.0177065. eCollection 2017.

    PubMed 28542256
  • Reupert, A., Maybery, D., Nicholson, J., Göpfert, M., & Seeman, M. V. (Eds.). (2015). Parental psychiatric disorder: Distressed parents and their families. Cambridge University Press.

  • Goodman SH, Rouse MH, Connell AM, Broth MR, Hall CM, Heyward D. Maternal depression and child psychopathology: a meta-analytic review. Clin Child Fam Psychol Rev. 2011 Mar;14(1):1-27. doi: 10.1007/s10567-010-0080-1.

    PubMed 21052833
  • O'Connor TG, Monk C, Burke AS. Maternal Affective Illness in the Perinatal Period and Child Development: Findings on Developmental Timing, Mechanisms, and Intervention. Curr Psychiatry Rep. 2016 Mar;18(3):24. doi: 10.1007/s11920-016-0660-y.

    PubMed 26830882
  • Dean K, Green MJ, Laurens KR, Kariuki M, Tzoumakis S, Sprague T, Lenroot R, Carr VJ. The impact of parental mental illness across the full diagnostic spectrum on externalising and internalising vulnerabilities in young offspring. Psychol Med. 2018 Oct;48(13):2257-2263. doi: 10.1017/S0033291717003786. Epub 2018 Jan 14.

    PubMed 29331151
  • Roos LE, Fisher PA, Shaw DS, Kim HK, Neiderhiser JM, Reiss D, Natsuaki MN, Leve LD. Inherited and environmental influences on a childhood co-occurring symptom phenotype: Evidence from an adoption study. Dev Psychopathol. 2016 Feb;28(1):111-25. doi: 10.1017/S0954579415000322. Epub 2015 Apr 8.

    PubMed 25851306
  • Shonkoff JP. Capitalizing on Advances in Science to Reduce the Health Consequences of Early Childhood Adversity. JAMA Pediatr. 2016 Oct 1;170(10):1003-1007. doi: 10.1001/jamapediatrics.2016.1559.

    PubMed 27548291
  • Chartier, M. (2016). The Mental Health of Manitoba's Children. Manitoba Centre for Health Policy, Rady Faculty of Health Sciences, Max Rady Colledge of Medicine, University of Manitoba.

  • Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T, Ferrari AJ, Hyman S, Laxminarayan R, Levin C, Lund C, Medina Mora ME, Petersen I, Scott J, Shidhaye R, Vijayakumar L, Thornicroft G, Whiteford H; DCP MNS Author Group. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet. 2016 Apr 16;387(10028):1672-85. doi: 10.1016/S0140-6736(15)00390-6. Epub 2015 Oct 8.

    PubMed 26454360
  • Waddell C, McEwan K, Peters RD, Hua JM, Garland O. Preventing mental disorders in children: a public health priority. Can J Public Health. 2007 May-Jun;98(3):174-8. doi: 10.1007/BF03403707.

    PubMed 17626379
  • Luthar SS, Eisenberg N. Resilient Adaptation Among At-Risk Children: Harnessing Science Toward Maximizing Salutary Environments. Child Dev. 2017 Mar;88(2):337-349. doi: 10.1111/cdev.12737. Epub 2017 Feb 1.

    PubMed 28144962
  • Shonkoff JP, Fisher PA. Rethinking evidence-based practice and two-generation programs to create the future of early childhood policy. Dev Psychopathol. 2013 Nov;25(4 Pt 2):1635-53. doi: 10.1017/S0954579413000813.

    PubMed 24342860
  • Aldao A, Gee DG, De Los Reyes A, Seager I. Emotion regulation as a transdiagnostic factor in the development of internalizing and externalizing psychopathology: Current and future directions. Dev Psychopathol. 2016 Nov;28(4pt1):927-946. doi: 10.1017/S0954579416000638.

    PubMed 27739387
  • Kochanska G, Philibert RA, Barry RA. Interplay of genes and early mother-child relationship in the development of self-regulation from toddler to preschool age. J Child Psychol Psychiatry. 2009 Nov;50(11):1331-8. doi: 10.1111/j.1469-7610.2008.02050.x. Epub 2009 Jan 12.

    PubMed 19207629
  • Strauman TJ. Self-Regulation and Psychopathology: Toward an Integrative Translational Research Paradigm. Annu Rev Clin Psychol. 2017 May 8;13:497-523. doi: 10.1146/annurev-clinpsy-032816-045012. Epub 2017 Mar 24.

    PubMed 28375727

Questions about this trial

What is this clinical trial studying?

A study testing BRIDGE Therapy Program in people with Depression and Self-regulation, run by University of Manitoba at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 18 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: The trial was ended after one year due to the suspension of in-person research as a result of the COVID-19 pandemic. We have returned to the program development stage as we explore telehealth alternative options.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Maternal Depression from pre-intervention to post-intervention - Beck Depression Inventory (time frame: The Beck Depression Inventory will be completed by participants at Time 1 prior to the beginning of the BRIDGE Therapy Program and at Time once again after the program is complete (approx. 20 weeks after Time 1).). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04347707, which also lists 35 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Building Regulation in Dual Generations (NCT04347707) | AzTrials